Reversal of P-glycoprotein-associated multidrug resistance: The challenge continues

This publication has 23 references indexed in Scilit:

• Multidrug Resistance
  Published by Springer Nature ,2011
• Intermittent high-dose tamoxifen as a potential modifier of multidrug resistance
  European Journal Of Cancer, 1992
• Resistance modification by PSC-833, a novel non-immunosuppressive cyclosporin A
  European Journal of Cancer and Clinical Oncology, 1991
• P‐glycoprotein expression and schedule dependence of adriamycin cytotoxicity in human colon carcinoma cell lines
  International Journal of Cancer, 1991
• Clinical Relevance of Immunohistochemical Detection of Multidrug Resistance P-Glycoprotein in Breast Carcinoma
  JNCI Journal of the National Cancer Institute, 1991
• Systemic Toxic Effects Associated With High-Dose Verapamil Infusion and Chemotherapy Administration
  JNCI Journal of the National Cancer Institute, 1991
• Expression of the multidrug resistance gene product (P-glycoprotein) in human normal and tumor tissues.
  Journal of Histochemistry & Cytochemistry, 1990
• Non-chemotherapeutic agents that potentiate chemotherapy efficacy
  Cancer Treatment Reviews, 1989
• Expression of Multidrug Resistance Gene in Human Cancers
  JNCI Journal of the National Cancer Institute, 1989
• Multidrug Resistance1
  JNCI Journal of the National Cancer Institute, 1988